Xiaolong Yang

Department of Pathology and Molecular Medicine, Queen's University

Affiliated withQueen's University Beigene (Beijing) Co., Ltd.

Research Area

Biography

Xiaolong Yang has not added Biography.
If you are Xiaolong Yang and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2	Year
Publication title Cited by 9	2018
Publication title Cited by 6	2019

Other Publications

Article	Year
Tumor suppressor LATS1 is a negative regulator of oncogene YAP. The Journal of biological chemistry\| PubMed ID: 18158288	2008
Molecular characterization of human homologs of yeast MOB1. International journal of cancer\| PubMed ID: 19739119	2010
Identification of LATS transcriptional targets in HeLa cells using whole human genome oligonucleotide microarray. Gene\| PubMed ID: 19799973	2010
MicroRNA-193b represses cell proliferation and regulates cyclin D1 in melanoma. The American journal of pathology\| PubMed ID: 20304954	2010
LATS tumor suppressor: a new governor of cellular homeostasis. Cell cycle (Georgetown, Tex.)\| PubMed ID: 20935475	2010
Taxol resistance in breast cancer cells is mediated by the hippo pathway component TAZ and its downstream transcriptional targets Cyr61 and CTGF. Cancer research\| PubMed ID: 21349946	2011
Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability [corrected]. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 21383157	2011
Molecular mechanism of size control in development and human diseases. Cell research\| PubMed ID: 21483452	2011
LATS1 tumor suppressor is a novel actin-binding protein and negative regulator of actin polymerization. Cell research\| PubMed ID: 21808298	2011
miR-193b Regulates Mcl-1 in Melanoma. The American journal of pathology\| PubMed ID: 21893020	2011
Tumour suppressor genes in chemotherapeutic drug response. Bioscience reports\| PubMed ID: 22762204	2012
Cell surface expression of human ether-a-go-go-related gene (hERG) channels is regulated by caveolin-3 protein via the ubiquitin ligase Nedd4-2. The Journal of biological chemistry\| PubMed ID: 22879586	2012
WWP1 E3 ligase targets LATS1 for ubiquitin-mediated degradation in breast cancer cells. PloS one\| PubMed ID: 23573293	2013
BMP4 is a novel transcriptional target and mediator of mammary cell migration downstream of the Hippo pathway component TAZ. Cellular signalling\| PubMed ID: 23673366	2013
Fer protein-tyrosine kinase promotes lung adenocarcinoma cell invasion and tumor metastasis. Molecular cancer research : MCR\| PubMed ID: 23699534	2013
YAP-induced resistance of cancer cells to antitubulin drugs is modulated by a Hippo-independent pathway. Cancer research\| PubMed ID: 24812269	2014
The Hippo pathway in chemotherapeutic drug resistance. International journal of cancer\| PubMed ID: 25348697	2015
Roles of the Hippo pathway in lung development and tumorigenesis. International journal of cancer\| PubMed ID: 25644176	2016
Recombinant hamster oviductin is biologically active and exerts positive effects on sperm functions and sperm-oocyte binding. PloS one\| PubMed ID: 25849110	2015
Hippo Component TAZ Functions as a Co-repressor and Negatively Regulates ΔNp63 Transcription through TEA Domain (TEAD) Transcription Factor. The Journal of biological chemistry\| PubMed ID: 25995450	2015
Regulation of sensitivity of tumor cells to antitubulin drugs by Cdk1-TAZ signalling. Oncotarget\| PubMed ID: 26183396	2015
WWTR1 (WW domain containing transcription regulator 1). Atlas of genetics and cytogenetics in oncology and haematology\| PubMed ID: 26366208	2014
The roles of the Hippo pathway in cancer metastasis. Cellular signalling\| PubMed ID: 27519476	2016
TAZ induces lung cancer stem cell properties and tumorigenesis by up-regulating ALDH1A1. Oncotarget\| PubMed ID: 28415606	2017
Essential signaling in loss-related tumours: the therapeutic potential of CRL4 and mTOR combined inhibition. Journal of thoracic disease\| PubMed ID: 29268334	2017
The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1. Cancer research\| PubMed ID: 29339539	2018
Cysteine residues are essential for dimerization of Hippo pathway components YAP2L and TAZ. Scientific reports\| PubMed ID: 29472569	2018
Identification of Cdk1-LATS-Pin1 as a Novel Signaling Axis in Anti-tubulin Drug Response of Cancer Cells. Molecular cancer research : MCR\| PubMed ID: 29523761	2018
A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis. Nature communications\| PubMed ID: 29535383	2018
PI3K Positively Regulates YAP and TAZ in Mammary Tumorigenesis Through Multiple Signaling Pathways. Molecular cancer research : MCR\| PubMed ID: 29545474	2018
The Hippo Pathway: Immunity and Cancer. Cancers\| PubMed ID: 29597279	2018
The Hippo pathway and cancer immunity: friend or foe? Oncoscience\| PubMed ID: 29854865	2018
TAZ enhances mammary cell proliferation in 3D culture through transcriptional regulation of IRS1. Cellular signalling\| PubMed ID: 30138697	2018